 Michael McNevin
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Prolapse | 2 | 2024 | 24 | 1.110 |
Why?
| | Fecal Incontinence | 2 | 2014 | 90 | 0.450 |
Why?
| | Electric Stimulation Therapy | 1 | 2014 | 62 | 0.390 |
Why?
| | Rectocele | 1 | 2010 | 4 | 0.310 |
Why?
| | Uterine Prolapse | 1 | 2010 | 14 | 0.310 |
Why?
| | Pelvic Floor | 1 | 2010 | 32 | 0.300 |
Why?
| | Fasciotomy | 1 | 2008 | 24 | 0.270 |
Why?
| | Hernia, Ventral | 1 | 2008 | 24 | 0.270 |
Why?
| | Appendicitis | 1 | 2008 | 150 | 0.240 |
Why?
| | Obesity, Morbid | 1 | 2008 | 293 | 0.200 |
Why?
| | Pancreaticojejunostomy | 1 | 1998 | 8 | 0.140 |
Why?
| | Surgical Wound Dehiscence | 1 | 1998 | 22 | 0.140 |
Why?
| | Aged, 80 and over | 6 | 2014 | 8346 | 0.120 |
Why?
| | Pancreas | 1 | 1998 | 341 | 0.120 |
Why?
| | Ischemia | 1 | 1998 | 422 | 0.110 |
Why?
| | Lumbosacral Plexus | 1 | 2014 | 10 | 0.100 |
Why?
| | Length of Stay | 2 | 2008 | 1350 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2014 | 11793 | 0.080 |
Why?
| | Defecography | 1 | 2010 | 3 | 0.080 |
Why?
| | Manometry | 1 | 2010 | 98 | 0.080 |
Why?
| | Feedback, Physiological | 1 | 2010 | 80 | 0.080 |
Why?
| | Urinary Incontinence | 1 | 2010 | 65 | 0.070 |
Why?
| | Anal Canal | 1 | 2010 | 102 | 0.070 |
Why?
| | Aged | 6 | 2014 | 26212 | 0.070 |
Why?
| | Endosonography | 1 | 2010 | 160 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2014 | 17322 | 0.070 |
Why?
| | Pancreatitis | 2 | 1999 | 146 | 0.070 |
Why?
| | Surgical Mesh | 1 | 2008 | 50 | 0.070 |
Why?
| | Electromyography | 1 | 2010 | 419 | 0.060 |
Why?
| | Suture Techniques | 1 | 2008 | 137 | 0.060 |
Why?
| | Middle Aged | 6 | 2014 | 36297 | 0.060 |
Why?
| | Humans | 11 | 2024 | 145750 | 0.060 |
Why?
| | Intestine, Small | 2 | 1997 | 167 | 0.060 |
Why?
| | Adult | 6 | 2014 | 40867 | 0.060 |
Why?
| | Postoperative Complications | 2 | 2008 | 2977 | 0.060 |
Why?
| | Recurrence | 1 | 2008 | 1139 | 0.050 |
Why?
| | Surgical Wound Infection | 1 | 2008 | 329 | 0.050 |
Why?
| | Female | 8 | 2014 | 79025 | 0.050 |
Why?
| | Adenocarcinoma | 2 | 2002 | 926 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5428 | 0.050 |
Why?
| | Comorbidity | 1 | 2008 | 1662 | 0.050 |
Why?
| | Male | 7 | 2014 | 72992 | 0.040 |
Why?
| | Pancreatic Neoplasms | 2 | 1999 | 928 | 0.040 |
Why?
| | Colonic Neoplasms | 1 | 2002 | 258 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2008 | 2933 | 0.040 |
Why?
| | Rectal Neoplasms | 1 | 2001 | 159 | 0.040 |
Why?
| | Laser-Doppler Flowmetry | 1 | 1998 | 31 | 0.040 |
Why?
| | Genes, ras | 1 | 1997 | 96 | 0.030 |
Why?
| | Quality of Life | 1 | 2010 | 3210 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 1998 | 421 | 0.030 |
Why?
| | Lymphoid Tissue | 1 | 1997 | 78 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 1998 | 514 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2002 | 1150 | 0.030 |
Why?
| | Laparoscopy | 1 | 1999 | 481 | 0.030 |
Why?
| | Adolescent | 2 | 2008 | 22569 | 0.030 |
Why?
| | Obesity | 1 | 2008 | 3118 | 0.030 |
Why?
| | Cell Cycle | 1 | 1997 | 599 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1997 | 534 | 0.020 |
Why?
| | Child, Preschool | 1 | 2008 | 11866 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 1997 | 675 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1023 | 0.020 |
Why?
| | Apoptosis | 1 | 1997 | 2443 | 0.020 |
Why?
| | Mice, Transgenic | 3 | 1997 | 2191 | 0.020 |
Why?
| | Child | 1 | 2008 | 22738 | 0.020 |
Why?
| | Antigens, Polyomavirus Transforming | 2 | 1997 | 15 | 0.020 |
Why?
| | Neoplasm Staging | 2 | 2002 | 1474 | 0.020 |
Why?
| | Colectomy | 1 | 2002 | 106 | 0.010 |
Why?
| | Radiotherapy Dosage | 1 | 2001 | 288 | 0.010 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2001 | 106 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 2002 | 770 | 0.010 |
Why?
| | Fluorouracil | 1 | 2001 | 231 | 0.010 |
Why?
| | Tomography, Emission-Computed | 1 | 1999 | 71 | 0.010 |
Why?
| | Cell Differentiation | 2 | 1997 | 2051 | 0.010 |
Why?
| | Pancreatic Ducts | 1 | 1999 | 82 | 0.010 |
Why?
| | Proportional Hazards Models | 1 | 2002 | 1330 | 0.010 |
Why?
| | Defensins | 1 | 1997 | 4 | 0.010 |
Why?
| | Simian virus 40 | 1 | 1997 | 24 | 0.010 |
Why?
| | Peyer's Patches | 1 | 1997 | 7 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2001 | 467 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1997 | 45 | 0.010 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 1997 | 14 | 0.010 |
Why?
| | bcl-X Protein | 1 | 1997 | 45 | 0.010 |
Why?
| | bcl-2-Associated X Protein | 1 | 1997 | 53 | 0.010 |
Why?
| | Jejunum | 1 | 1997 | 37 | 0.010 |
Why?
| | Diphtheria Toxin | 1 | 1997 | 65 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1997 | 414 | 0.010 |
Why?
| | Integrins | 1 | 1997 | 90 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 546 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1082 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 241 | 0.010 |
Why?
| | Mice | 3 | 1997 | 18357 | 0.010 |
Why?
| | Cell Lineage | 1 | 1997 | 378 | 0.010 |
Why?
| | Ultrasonography | 1 | 1999 | 788 | 0.010 |
Why?
| | Ligands | 1 | 1997 | 668 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1999 | 1512 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 1997 | 625 | 0.010 |
Why?
| | Homeostasis | 1 | 1997 | 644 | 0.010 |
Why?
| | Membrane Proteins | 1 | 1997 | 1166 | 0.010 |
Why?
| | Animals | 3 | 1997 | 38100 | 0.010 |
Why?
| | Phenotype | 1 | 1997 | 3170 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1999 | 2770 | 0.000 |
Why?
| | Gene Expression Regulation | 1 | 1997 | 2601 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1997 | 5992 | 0.000 |
Why?
|
|
McNevin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|